Hytro key facts
as of Oct 2026- Developer of a wearable device designed to help athletes build muscle and recover efficiently.
- Hytro is valued at approximately $10.0M as of Oct 2026 (last reported valuation).
- It has raised $4.5M; the latest was Later Stage VC in Jul 2025.
- Notable investors include The FSE Group, Lince Capital, Brinyhold, Cameron Norrie, Casey Toohill — 9 tracked in total.
- Status: Privately Held (backing).
Hytro's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch Hytro: the Monday email on marks, rounds and moves
Hytro funding rounds
No funding rounds for Hytro are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Hytro valuation
Hytro's last reported valuation was $10 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
Hytro investors
9 investors are on record for Hytro, including The FSE Group, Lince Capital, Brinyhold and Cameron Norrie.
About Hytro
Developer of a wearable device designed to help athletes build muscle and recover efficiently. The company's device allows oxygenated blood to flow to the muscles but restricts the amount that then returns to the heart, enabling athletes to enhance muscle size and strength and improve sports performance.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Surrey, United Kingdom
- Founded
- 2018
- Employees
- 5
- Website
- hytro.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.